Page 1 | Search Results | Blood | American Society of Hematology

1-7 of 7

Sort by

Sort Order Select

Journal Articles

Tissue Resident Memory Cells

Thomas S Kupper, MD

Blood (2018) 132 (Supplement 1): SCI-5.

https://doi.org/10.1182/blood-2018-99-109534

Published: 2018

Journal Articles

A Functional Characterization of BCL2-Family Members Identifies BH3 Mimetics As Potential Therapeutics in T-Cell Lymphomas

Raphael Koch, MD, Elizabeth Brem, MD, Rachael Clark, MD PhD, Thomas S. Kupper, MD, Anthony Letai, MD PhD, David M. Weinstock, MD

Blood (2016) 128 (22): 292.

https://doi.org/10.1182/blood.V128.22.292.292

Published: 2016

Journal Articles

Decitabine Priming Enhances Mucin 1 Inhibition Mediated Disruption of Redox Homeostasis in Cutaneous T-Cell Lymphoma

Salvia Jain, MD, Abigail J. Washington, BA, Rebecca Karp Leaf, MD, Parul Bhargava, MD, Rachael Clark, MD PhD, Thomas S. Kupper, MD, Dina Stroopinsky, PhD, Athalia Rachel Pyzer, MD, Leandra Cole, BA, Myrna R. Nahas, MD, Arie Apel, MD, Jacalyn Rosenblatt, MD, Jon Arnason, MD, Donald Kufe, MD, David E. Avigan, MD

Blood (2016) 128 (22): 4175.

https://doi.org/10.1182/blood.V128.22.4175.4175

Published: 2016

Journal Articles

MUC1 As a Potential Therapeutic Target in Cutaneous T-Cell Lymphoma

Salvia Jain, MD, Maroof Alam, PhD, Hasan Rajabi, PhD, Dina Stroopinsky, PhD, Li Yin, PhD, Jacalyn Rosenblatt, MD, Kristen A Palmer, Maxwell Douglas Coll, Athalia Rachel Pyzer, MD, Katarina Luptakova, MD, Jon Arnason, MD, Robin Joyce, MD, Michal Bar-Natan, MD, Poorvi Somaiya, MSc, Rachael A Clark, MDPhD, Thomas S. Kupper, MD, Donald Kufe, MD, David Avigan, MD

Blood (2014) 124 (21): 808.

https://doi.org/10.1182/blood.V124.21.808.808

Published: 2014

Journal Articles

High Throughput TCR Sequencing Provides Added Value in the Diagnosis of Cutaneous T-Cell Lymphoma

Ilan Kirsch, MD, David W Williamson, PhD, James Krueger, MD PhD, Jessica Teague, PhD, Christopher Elco, MD PhD, Harlan Robins, PhD, Thomas S. Kupper, MD, Rachael A Clark, MDPhD

Blood (2014) 124 (21): 1683.

https://doi.org/10.1182/blood.V124.21.1683.1683

Published: 2014

Journal Articles

Sezary Syndrome Is a Malignancy of Central Memory T Cells with Skin Homing Properties, While Mycosis Fungoides Is a Malignancy of Skin Homing Effector Memory T Cells.

James Campbell, PhD, Rachael A Clark, MD, PhD, Thomas S. Kupper, MD

Blood (2009) 114 (22): 3954.

https://doi.org/10.1182/blood.V114.22.3954.3954

Published: 2009

Journal Articles

Low-Dose Alemtuzumab Is Uniquely Effective in Refractory Leukemic Cutaneous T Cell Lymphoma (L-CTCL).

David C. Fisher, MD, Marianne Tawa, Michele Walsh, Nurse, Practioner, Rachael A Clark, MD, PhD, Thomas S. Kupper, MD

Blood (2009) 114 (22): 3748.

https://doi.org/10.1182/blood.V114.22.3748.3748

Published: 2009

NARROW

Tissue Resident Memory Cells

A Functional Characterization of BCL2-Family Members Identifies BH3 Mimetics As Potential Therapeutics in T-Cell Lymphomas

Decitabine Priming Enhances Mucin 1 Inhibition Mediated Disruption of Redox Homeostasis in Cutaneous T-Cell Lymphoma

MUC1 As a Potential Therapeutic Target in Cutaneous T-Cell Lymphoma

High Throughput TCR Sequencing Provides Added Value in the Diagnosis of Cutaneous T-Cell Lymphoma

Sezary Syndrome Is a Malignancy of Central Memory T Cells with Skin Homing Properties, While Mycosis Fungoides Is a Malignancy of Skin Homing Effector Memory T Cells.

Low-Dose Alemtuzumab Is Uniquely Effective in Refractory Leukemic Cutaneous T Cell Lymphoma (L-CTCL).

Email alerts

ASH Publications

American Society of Hematology

Tissue Resident Memory Cells

A Functional Characterization of BCL2-Family Members Identifies BH3 Mimetics As Potential Therapeutics in T-Cell Lymphomas

Decitabine Priming Enhances Mucin 1 Inhibition Mediated Disruption of Redox Homeostasis in Cutaneous T-Cell Lymphoma

MUC1 As a Potential Therapeutic Target in Cutaneous T-Cell Lymphoma

High Throughput TCR Sequencing Provides Added Value in the Diagnosis of Cutaneous T-Cell Lymphoma

Sezary Syndrome Is a Malignancy of Central Memory T Cells with Skin Homing Properties, While Mycosis Fungoides Is a Malignancy of Skin Homing Effector Memory T Cells.

Low-Dose Alemtuzumab Is Uniquely Effective in Refractory Leukemic Cutaneous T Cell Lymphoma (L-CTCL).

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only